4.6 Review

Inhibition of Serine Proteases as a Novel Therapeutic Strategy for Abdominal Pain in IBS

Journal

FRONTIERS IN PHYSIOLOGY
Volume 13, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fphys.2022.880422

Keywords

irritable bowel syndrome; visceral hypersensitivity; proteases; protease-activated receptors; protease inhibitors

Categories

Funding

  1. FWO PhD fellowship [11B8920N]
  2. FWO-SBO grant [S001017N]

Ask authors/readers for more resources

Serine proteases play a crucial role in the development of abdominal pain in irritable bowel syndrome (IBS), and protease inhibitors are emerging as a potential therapeutic tool. However, the identity of dysregulated serine proteases released by the rectal mucosa of IBS patients remains poorly understood, highlighting a knowledge gap that needs to be addressed with advanced techniques.
Serine proteases are heavily present in the gastrointestinal tract where they are essential in numerous physiological processes. An imbalance in the proteolytic activity is a central mechanism underlying abdominal pain in irritable bowel syndrome (IBS). Therefore, protease inhibitors are emerging as a promising therapeutic tool to manage abdominal pain in this functional gastrointestinal disorder. With this review, we provide an up-to-date overview of the implications of serine proteases in the development of abdominal pain in IBS, along with a critical assessment of the current developments and prospects of protease inhibitors as a therapeutic tool. In particular, we highlight the current knowledge gap concerning the identity of dysregulated serine proteases that are released by the rectal mucosa of IBS patients. Finally, we suggest a workflow with state-of-the-art techniques that will help address the knowledge gap, guiding future research towards the development of more effective and selective protease inhibitors to manage abdominal pain in IBS.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available